About
Aeglea BioTherapeutics, Inc is a biopharmaceutical company developing human enzyme therapeutics targeting rare genetic diseases.
Explore Aeglea BioTherapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.